Web Analytics
Cổ phiếu PALI (NASDAQ) | PALISADE BIO INC – Phân tích Deepscope
MARKET

Select Market Data Region

PALI — PALISADE BIO INC (Healthcare >> Biotechnology)

PALI FAQ

What is PALI's ROE?

PALISADE BIO INC reports a Return on Equity (ROE) of -18.96%.

What is PALI's dividend yield?

PALISADE BIO INC offers a dividend yield of 0.00%.

What is PALI's Deepscope Quality Score?

Deepscope rates PALI's overall financial quality at 15 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy PALI?

Deepscope's AI Timing Score for PALI is 27 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does PALI belong to?

PALISADE BIO INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-11 | FS: 2026-03-31)

PALI

PALISADE BIO INC
USD 1.78
0.10 (5.95%) Day Change
0.05
D/E
-19.0%
ROE
-18.1%
ROA
0.00%
Div Yield
USD 1.78
Price
0.10 (5.95%)
Day Change
NEWS SCORE: 98

PALI Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 15) và Thời điểm mua ...(Sign In to See)...

15

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng 42%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 98
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 1.78
  PBV / Sector
2.28 / 4.79
  Earning Per Share -0.15
  PE / Sector
N/A / 18.05
  PEG or PE/Growth / Sector
N/A / 0.62
  Average 1M Daily Value
5.01 M
GREAT
  Average 1W Daily Value
4.01 M
GREAT
Yếu tố Kỹ thuật 14%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Sức khỏe tài chính 45%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Khả năng kiếm lợi nhuận 43%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
N/A / 468.85
  NPM Average (%) / Sector
-5,312.00 / -1,531.69
  NPM Change Average (%) / Sector
N/A / 5,028.65
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-18.12 / 31.69
  ROA Average (%) / Sector
-68.26 / -353.18
  ROA Change Average (%) / Sector
0.70 / 5,214.65
  ROE (%) / Sector
-18.96 / 10.58
  ROE Average (%) / Sector
-89.53 / 27.64
  ROE Change Average (%) / Sector
6.33 / 2,048.88
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Lợi tức cho nhà đầu tư 4%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 4.77
Chi tiết đăng ký
X
  Analyze Date 2026-06-12 09:43:53
  Symbol PALI
  Name PALISADE BIO INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 173.58 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 290.21 / 9,010.81
Tin tức, Dự báo ước tính
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 4600 South Syracuse Street, Denver, CO, United States, 80237

Phone: 858 704 4900

Website: https://www.palisadebio.com

Sector: Healthcare >> Biotechnology

Description: Palisade Bio, Inc., a clinical-stage biopharmaceutical company, engages in developing oral phosphodiesterase-4 inhibitor prodrugs designed for targeted delivery to the terminal ileum and colon in the United States. Its lead clinical product candidate includes PALI-2108, which is in phase 1b clinical trial to treat patients with inflammatory bowel disease, including ulcerative colitis and Fibrostenotic Crohn's disease. The company has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company was founded in 2001 and is headquartered in Denver, Colorado.

ME vs SECTOR Healthcare >> Biotechnology

PALI (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
PALI
PALI
USD 1.78 (5.95%)
+ Watch + Port Chart